Negara: Siprus
Bahasa: Yunani
Sumber: Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας
SULFADIAZINE; NEOMYCIN SULFATE
PANCHRIS FEEDS (VETERINARY) LTD (0000003032) INDUSTRIAL ZONE ARADIPPOU, 7100 LARNACA, P O BOX 40261
QJ01RA02
SULFONAMIDES, COMB WITH OTHER ANTIBACTERIALS EXCL TRIMETHOPRIM
150 + 25 MG/ML
ORAL SUSPENSION
SULFADIAZINE (0000068359) 150MG; NEOMYCIN SULFATE (0001405103) 25MG
ORAL USE
Εθνική Διαδικασία
SULFONAMIDES, COMB WITH OTHER ANTIBACTERIALS EXCL TRIMETHOPRIM
Νομικό καθεστώς: Με Ιατρική Συνταγή; VIAL X 250 ML (20V037301) 250 MILLILITRE - Εγκεκριμένο - Με Ιατρική Συνταγή
ΠΑΡΑΡΤΗΜΑ 2: ΦΥΛΛΟ ΟΔΗΓΙΩΝ ΧΡΗΣΗΣ Το προϊόν αυτό, δεν έχει φύλλο οδηγιών χρήσης. Όλες οι πληροφορίες αναγράφονται στην στοιχειώδη συσκευασία. 1/1 Baca dokumen lengkapnya
ΠΑΡΑΡΤΗΜΑ 1: ΠΕΡΙΛΗΨΗ ΤΩΝ ΧΑΡΑΚΤΗΡΙΣΤΙΚΩΝ ΤΟΥ ΠΡΟΪΟΝΤΟΣ 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Bimastat Oral Suspension for pre-ruminant calves 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCES: Sulfadiazine 150 mg/ml Neomycin (as neomycin sulphate) 25 mg/ml EXCIPIENTS: Methyl parahydroxybenzoate 2.0 mg/ml Propyl parahydroxybenzoate 0.2 mg/ml Carmoisine E122 0.05 mg/ml For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Oral suspension. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Pre-ruminant calves. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of diarrhoea in pre-ruminant calves associated with infections caused by organisms known to be, or suspected of being, susceptible to the combination of sulfadiazine and neomycin. 4.3 CONTRAINDICATIONS Do not use in animals with know hypersensitivity to the active ingredient. Do not exceed the recommended dosage or the period of treatment. Do not use local anesthetics of the procaine group during treatment as they are antagonistic to the sulphonamide component. Do not use in calves with functional rumens. Do not use in lactating cows. Do not use in foals and horses. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Concurrent intravenous fluid therapy should be considered in dehydrated calves. Parenteral antibiotic treatment should be considered if a clinical response is not seen after 48 hours treatment. 1/4 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy should be based on local (regional, farm level) epidemiological information about susceptibility of the target bacteria. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS Avoid contact with skin. Wash hands after use. 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) Chronic usage of oral neomycin may result Baca dokumen lengkapnya